Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 5
1999 1
2000 4
2001 8
2002 12
2003 10
2004 11
2005 9
2006 6
2007 8
2008 15
2009 14
2010 18
2011 14
2012 16
2013 21
2014 22
2015 17
2016 29
2017 19
2018 17
2019 21
2020 23
2021 25
2022 18
2023 15
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

335 results

Results by year

Filters applied: . Clear all
Page 1
Systematic review: Glycomics as diagnostic markers for hepatocellular carcinoma.
Butaye E, Somers N, Grossar L, Pauwels N, Lefere S, Devisscher L, Raevens S, Geerts A, Meuris L, Callewaert N, Van Vlierberghe H, Verhelst X. Butaye E, et al. Among authors: van vlierberghe h. Aliment Pharmacol Ther. 2024 Jan;59(1):23-38. doi: 10.1111/apt.17748. Epub 2023 Oct 25. Aliment Pharmacol Ther. 2024. PMID: 37877758 Review.
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Qin S, Chen M, Cheng AL, Kaseb AO, Kudo M, Lee HC, Yopp AC, Zhou J, Wang L, Wen X, Heo J, Tak WY, Nakamura S, Numata K, Uguen T, Hsiehchen D, Cha E, Hack SP, Lian Q, Ma N, Spahn JH, Wang Y, Wu C, Chow PKH; IMbrave050 investigators. Qin S, et al. Lancet. 2023 Nov 18;402(10415):1835-1847. doi: 10.1016/S0140-6736(23)01796-8. Epub 2023 Oct 20. Lancet. 2023. PMID: 37871608 Clinical Trial.
An unusual cause of portal hypertension.
Ferdinande K, Lamiroy T, Hoorens A, Verhelst X, Degroote H, Raevens S, Van Vlierberghe H, Geerts A. Ferdinande K, et al. Among authors: van vlierberghe h. Acta Gastroenterol Belg. 2023 Jul-Sep;86(3):509-510. doi: 10.51821/86.3.11925. Acta Gastroenterol Belg. 2023. PMID: 37814574 Free article. No abstract available.
A remarkable presentation of a massive Budd-Chiari syndrome.
Ferdinande K, Degroote H, Geerts A, Van Vlierberghe H, Verhelst X, Raevens S. Ferdinande K, et al. Among authors: van vlierberghe h. Acta Gastroenterol Belg. 2023 Jul-Sep;86(3):503-504. doi: 10.51821/86.3.11994. Acta Gastroenterol Belg. 2023. PMID: 37814571 Free article. No abstract available.
Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis.
De Muynck K, Heyerick L, De Ponti FF, Vanderborght B, Meese T, Van Campenhout S, Baudonck L, Gijbels E, Rodrigues PM, Banales JM, Vesterhuus M, Folseraas T, Scott CL, Vinken M, Van der Linden M, Hoorens A, Van Dorpe J, Lefere S, Geerts A, Van Nieuwerburgh F, Verhelst X, Van Vlierberghe H, Devisscher L. De Muynck K, et al. Among authors: van vlierberghe h. Hepatology. 2024 Feb 1;79(2):269-288. doi: 10.1097/HEP.0000000000000557. Epub 2023 Aug 2. Hepatology. 2024. PMID: 37535809 Free PMC article.
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial.
Yuen MF, Asselah T, Jacobson IM, Brunetto MR, Janssen HLA, Takehara T, Hou JL, Kakuda TN, Lambrecht T, Beumont M, Kalmeijer R, Guinard-Azadian C, Mayer C, Jezorwski J, Verbinnen T, Lenz O, Shukla U, Biermer M; REEF-1 Study Group. Yuen MF, et al. Lancet Gastroenterol Hepatol. 2023 Sep;8(9):790-802. doi: 10.1016/S2468-1253(23)00148-6. Epub 2023 Jul 10. Lancet Gastroenterol Hepatol. 2023. PMID: 37442152 Clinical Trial.
Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease.
Gijbels E, De Muynck K, Vanderborght B, Meese T, Van Nieuwerburgh F, Vanlander A, Berrevoet F, Hendrikx B, Hoorens A, Van Vlierberghe H, Vinken M, Devisscher L. Gijbels E, et al. Among authors: van vlierberghe h. Genes Dis. 2022 Mar 14;10(1):18-21. doi: 10.1016/j.gendis.2022.02.003. eCollection 2023 Jan. Genes Dis. 2022. PMID: 37013051 Free PMC article. No abstract available.
Transient Kupffer cell depletion and subsequent replacement by infiltrating monocyte-derived cells does not alter the induction or progression of hepatocellular carcinoma.
Vanderborght B, De Muynck K, Gijbels E, Lefere S, Scott CL, Guilliams M, Beschin A, Vinken M, Verhelst X, Geerts A, Van Vlierberghe H, Devisscher L. Vanderborght B, et al. Among authors: van vlierberghe h. Int J Cancer. 2023 Jun 15;152(12):2615-2628. doi: 10.1002/ijc.34505. Epub 2023 Mar 20. Int J Cancer. 2023. PMID: 36912275
335 results